Clinical Hematology Series

Acute Leukemia

From origin to emergency — pathogenesis, diagnosis, and the oncologic emergencies.

15 slides·English·2026
Download PDF
Slides
0%
Title slide with a watercolor blood-smear illustration labeling a healthy neutrophil, clustered leukemic blasts, and a schistocyte (red blood cell fragment).
01 / 15

Acute Leukemia: Pathogenesis, Diagnosis, and Emergency Management

A comprehensive review of the ‘Broken Factory’: From genetic triggers to life-saving interventions.

  • 1. Physiology: The Blueprint of Hematopoiesis
  • 2. Pathology: The Genetic Glitch and Maturation Arrest
  • 3. Diagnosis: Beyond the White Blood Cell Count
  • 4. Acute Oncology: Recognizing and Managing Emergencies

Illustration labels: Healthy Neutrophil; Leukemic Blasts; Schistocyte (Red Blood Cell Fragment).

A lineage tree showing how a multipotential hematopoietic stem cell differentiates through myeloid and lymphoid progenitors into all mature blood cell types, organized by bone marrow and peripheral blood tiers.
02 / 15

The Factory of Life: Normal Hematopoiesis

The chart is organized into three anatomical/functional tiers on the left: Bone Marrow (Production); Committed Progenitor Cells; and Peripheral Blood (Functional).

Differentiation flow:

  • Multipotential Hematopoietic Stem Cell (Hemocytoblast) → gives rise to the Common Myeloid Progenitor and the Common Lymphoid Progenitor.
  • Common Myeloid Progenitor → Megakaryocyte, Erythroblast, and Myeloblast.
    • Megakaryocyte → Platelets (Thrombopoiesis).
    • Erythroblast → Red Blood Cells (Erythropoiesis).
    • Myeloblast → Granulocytes (Neutrophil, Eosinophil, Basophil) and Monocytes.
  • Common Lymphoid Progenitor → Lymphoblast → B Lymphocyte, T Lymphocyte, and Natural Killer Cell.

Annotation on the central maturation arrow: “Process of Differentiation: Maturation couples with Division.”

A diagram of normal bone marrow with labeled structures beside paired histology photomicrographs contrasting healthy marrow with densely packed leukemic marrow.
03 / 15

The Architecture of the Bone Marrow

Labeled structures on the marrow illustration: Hematopoietic Island; Fat Cell (Adipose); Sinusoid; Central Longitudinal Vein.

Two comparison micrographs are shown: “Healthy Marrow” and “Leukemic Marrow”.

Normal Composition: Active cellular islands nestled within fatty spaces. Cellularity is high at birth and decreases with age.

Pathology: In Leukemia, cellularity reaches ~100%, crowding out normal production.

A cell-signaling diagram showing a growth factor binding a surface receptor and a DNA mutation branching into two consequences, proliferation advantage and maturation arrest.
04 / 15

The Genetic Glitch: Where It All Starts

A Growth Factor binds a cell-surface receptor, triggering intracellular signaling to the nucleus, where a Mutation strikes the DNA. This branches into two outcomes (labeled The Two-Hit Theory):

  • Proliferation Advantage: Division-promoting genes are stuck “ON”. Cells divide uncontrollably.
  • Maturation Arrest: Differentiation genes are blocked. Cells stop developing at the Blast stage. (Illustration labeled “Blasts”.)

Result: Accumulation of immature, non-functional clones.

A two-column comparison contrasting acute leukemia as a blocked assembly line producing uniform blasts against chronic leukemia as an overactive factory producing diverse mature cells.
05 / 15

Clinical Editorial

Acute vs. Chronic: Understanding the Difference

Acute Leukemia (AML/ALL)Chronic Leukemia (CML/CLL)
The Blocked Assembly LineThe Overactive Factory
Mechanism: Maturation Arrest + Proliferation.Mechanism: Proliferation Advantage ONLY (No arrest).
Marrow: Packed with Blasts (>20%). Normal production stops.Marrow: Hypercellular but maturation continues.
Clinical: Rapid Marrow Failure (Pancytopenia).Clinical: Organomegaly (Spleen/Liver). Often no initial failure.
Timecourse: Aggressive, days to weeks.Timecourse: Indolent, months to years.

Each panel diagram shows a Blood Stem Cell giving rise to its cell population. (Note: the subtitle text “Crimson Pro Regular” appears under both column headings as a leftover font-placeholder label.)

A human body figure flanked by two symptom categories, marrow failure on the left and tissue infiltration on the right, each with labeled clinical features pointing to body regions.
06 / 15

The Clinical Picture: When the Factory Fails

Marrow Failure (Pancytopenia)

  • Anemia (Low RBC) → Breathlessness, Fatigue, Pallor
  • Neutropenia (Low WBC) → Recurrent Infections, Mouth Ulcers, Fever
  • Thrombocytopenia (Low Platelets) → Bleeding, Bruising, Petechiae

Tissue Infiltration

  • Deep Bone Pain (Marrow expansion)
  • Lymphadenopathy
  • Hepatosplenomegaly
  • Gum Hypertrophy (Specific to AML)

Symptoms arise from two causes:

  • 1. The absence of healthy cells (Failure).
  • 2. The overcrowding of leukemic cells (Infiltration).
A Complete Blood Count panel with warning icons beside abnormal values next to a Clinical Pearl box explaining not to be misled by the total WBC count.
07 / 15

The Diagnostic Detective: Suspecting Leukemia from the CBC

Complete Blood Count

  • Hemoglobin: LOW (<10 g/dL)
  • Platelets: LOW (<100 x10^9/L)
  • Neutrophils: LOW (<1.0 x10^9/L)
  • Total WBC: VARIABLE (High, Normal, or Low)

Clinical Pearl — The Golden Rule: Do not be misled by the Total WBC.

  • WBC count can be misleading. It may be normal or low (Aleukemic Leukemia).
  • The true clue is Pancytopenia: Low Hb + Low Platelets + Low Neutrophils.
  • Always check the Differential: The machine may miscount Blasts as ‘Lymphocytes’ or ‘Monocytes’.

Acute Leukemia is almost always associated with pancytopenia, regardless of the total white cell count. (Bottom line partially cut off at slide edge.)

A magnified blood-smear illustration highlighting a blast cell's features with a numbered list, plus an inset showing an Auer rod, alongside a note on morphological monotony.
08 / 15

The Peripheral Smear: Identifying the Enemy

Numbered features of the leukemic blast:

  • 1. High Nuclear-to-Cytoplasmic Ratio (Large nucleus, little cytoplasm).
  • 2. Prominent Nucleoli (Pale circles inside the nucleus).
  • 3. Open, lacey chromatin pattern.

Inset label: Auer Rod (Pathognomonic for AML).

Morphological Hallmark: Monotony.

In a healthy smear, you see a diversity of cells.

In Acute Leukemia, the field is monotonous, filled with identical immature clones.

A workflow from bone marrow biopsy and microscopy to a flow cytometry laser diagram, with a table mapping CD markers to leukemia lineages.
09 / 15

Confirming the Verdict: Biopsy and Immunophenotyping

Bone Marrow Assessment

>20% Blasts required for diagnosis.

Cellularity often ~100% (Packed Marrow).

Flow Cytometry (Immunophenotyping) — The Gold Standard for Classification.

CD MarkersMyeloid (AML)B-Lymphoid (ALL)T-Lymphoid (ALL)
CD13, CD33, CD117, MPO (Myeloperoxidase)CD19, CD20, CD79aCD3, CD7

Diagnosis relies on Morphology (Counting the blasts) and Flow Cytometry (Naming the blasts). (Bottom line partially cut off at slide edge.)

Five icon cards across the slide naming acute leukemia emergencies, each with a short descriptor.
10 / 15

Acute Oncology: Red Flags and Emergencies

Time is Critical. Early recognition saves lives.

  • Febrile Neutropenia: Infection without defense. Sepsis risk.
  • Tumor Lysis Syndrome: Metabolic overload from dying cells.
  • Hyperleukocytosis: WBC >100k causing Leukostasis.
  • DIC (Coagulopathy): Bleeding & Clotting. Specific to APL (M3).
  • SVCO: Superior Vena Cava Obstruction (T-cell ALL).
Two panels: a lysing cell releasing potassium, phosphate and uric acid for Tumor Lysis Syndrome, and a blood tube with a bruise illustration for Disseminated Intravascular Coagulation.
11 / 15

Emergency Management: Metabolic & Coagulation

Tumor Lysis Syndrome (TLS)

The lysing cell releases: Potassium (K+); Phosphate (PO4); Uric Acid.

  • Mechanism: Massive cell death releases toxic intracellular contents.
  • The Triad: Hyperuricemia, Hyperkalemia, Hyperphosphatemia.
  • Risk: Acute Renal Failure & Arrhythmias.
  • Action: Aggressive Hydration, Allopurinol, Rasburicase.

Disseminated Intravascular Coagulation (DIC)

  • High Risk: Acute Promyelocytic Leukemia (APL/M3).
  • Signs: Ecchymoses, bleeding from IV sites, abnormal clotting screen.
  • Action: Immediate blood product support (FFP, Cryoprecipitate, Platelets).
Two panels: a vessel clogged with white cells illustrating leukostasis, and a red MEDICAL EMERGENCY shield illustrating febrile neutropenia.
12 / 15

Emergency Management: Mechanical & Infectious

Leukostasis (Hyperleukocytosis)

  • Threshold: WBC >100 x 10^9/L.
  • Symptoms: Hypoxia (Lung sludge), Confusion/Stroke (Brain sludge), Visual blurring.
  • Action: Cytoreduction (Hydroxyurea) and Leukapheresis.

Febrile Neutropenia (marked MEDICAL EMERGENCY)

  • Definition: Fever (>38°C) in a patient with neutrophils <0.5.
  • The Danger: Signs of inflammation are absent due to lack of neutrophils.
  • Action: Door-to-Needle time < 60 mins. Start broad-spectrum antibiotics immediately. Do not wait for labs.
Three chevron arrows in sequence labeled Supportive Care, Induction Therapy, and Consolidation, each with bulleted actions and icons.
13 / 15

The Treatment Roadmap

Supportive Care

  • Reverse Isolation (Infection control).
  • Transfuse Platelets (Target >10k).
  • Transfuse RBCs (Target Hb >8).

Induction Therapy

  • Intensive Chemotherapy.
  • Goal: Kill blasts & empty the marrow (Remission).

Consolidation

  • Eliminate residual disease.
  • Chemotherapy OR Allogenic Stem Cell Transplant.
  • Choice depends on Risk Profile (Cytogenetics).

Prognosis relies heavily on Cytogenetics and Molecular Mutations.

A checklist of five bolded clinical takeaways, each marked with a red check mark.
14 / 15

Clinical Pearls & Key Takeaways

  • Suspect Pancytopenia. Acute leukemia presents with failure of all cell lines. The Neutrophil count is almost always low.”
  • Ignore Total WBC. A normal total WBC does not rule out leukemia. Look at the Differential.
  • The 20% Rule. Diagnosis requires >20% Blasts in the Bone Marrow.
  • Act Fast. Identify emergencies (Sepsis, Lysis, Bleeding) immediately. Time is the most critical factor in Acute Oncology.
  • The Human Side. Breaking bad news is a skill. Treat with curative intent, but apply palliative principles from day one.

(Note: each bullet is followed by a leftover font-placeholder label reading “(Crimson Pro, Regular)”, variously mistyped as “Crmson” and “Crinson”.)

A line drawing of a clinician's hand clasping a patient's hand, above the motto Cure sometimes... Care always.
15 / 15

The Human Element

Cure sometimes… Care always.

The journey of Acute Leukemia is long and arduous. While we focus on blasts, genes, and counts, we must never lose sight of the person behind the diagnosis. Compassion is as vital as chemotherapy.